REGENERATIVE MEDICINE: FROM BASIC RESEARCH TO ORTHOPAEDIC APPLICATIONS AND BEYOND.
Chairs of the sessions are expected to introduce the speakers and guide the discussion at the end of the round table.
Lunes 25
Martes 26
Miércoles 27
Jueves 28
9:30-11:30
9:30-11:30
9:30-11:30
9:30-11:30
ROUND TABLE: Basic aspects ROUND TABLE: Cartilage cells ROUND TABLE: MSCs
in bone regeneration. Chair: and regeneration. Chair: Yrjö production. Chair: Rosaria
Nuria Vilaboa.
Konttinen
Giordano.
10:00-10:30
Official opening: EGB, YTK,
Javier
Arias
(Vice
Directorate General of
research on Cell Therapy
and
Regenerative
Medicine,
Ministry
of
Science and Innovation),
Javier
Llorca
(Dean,
Cantabria Medical School),
José Antonio Rodriguez
Montes
(Dean,
UAM
Medical School)
9:30-10:00
Stem
cells
for
bone
reconstruction.
Overview.
Gabriela Ciapetti
Istituto Ortopedico Rizzoli,
Bologna, Italy
10:30-10:50
Overall view on the
orthopaedic needs for
regenerative
medicine.
Enrique
Gomez-Barrena
egbarrena@telefonica.net
Spain
10:20-10:40
Adult bone marrow and
umbilical cord blood stem cells
in experimental critical bone
defects and nonunions Viorel
Nacu nacu_viorel@yahoo.com
10:50-11:05
Orthobiologics:
present
state
of
commercial
proposals. EGB
10:40-11:00 Recombinant
Human Platelet-Derived
Growth Factor-BB and
guided tissue regeneration
Victor Palarie
vpalarie@gmail.com
DISCUSSION:
11:05-11:15
BREAK
11:15-11:30
gabriela.ciapetti@ior.it
10:00-10:20
Endothelial cells influence
osteogenic potential. Ying Xue
Ying.xue@uib.no
University of Bergen,
Bergen, Norway
DISCUSSION: 11:00-11:15
9:30-10:00
Chondrogenic potential of
stem cells for cartilage
reconstruction. Francisco J
Blanco, Spain
francisco.blanco.garcia@serga
s.es
9:30-10:00
Bone marrow MSCs in clinical
setting. M. Fernandez
Universidad Autónoma de
Madrid, Hospital Puerta de
Hierro. Madrid, Spain
manueln.fernandez@uam.es
10:00-10:30
Stem cells in osteoarthritis
Gerben
van
Buul,
g.vanbuul@erasmusmc.nl
Holland
10:00-10:30
Platelet-lysate to expand
MSCs for osteogenic human
application. H. Schrezenmeier
(Ulm)
Germany
h.schrezenmeier@blutspende.
de
10:30-11:00
Sources of cells to reconstruct
cartilage: the role of synovial
and amniotic membrane.
Francisco J Blanco,Hospital
Universitario A Coruña, Spain
francisco.blanco.garcia@serg
as.es
11:00-11:15
Round table discussion on
cartilage regeneration.
Viernes 29
9:30-11:30
ROUND TABLE: Other sources
of cells. Chair: Thimios
Mitsiadis
9:30-10:00
MSCs from other origins:
dissecting
sources
and
isolation
approaches
for
optimized bone and cartilage
reconstructions.M. Dominici.
University of Modena, Italy.
massimo.dominici@unimore.it
10:00-10:30
Mesenchymal stem cells
derived from human term
deciduas. Ana Flores de la Cal.
Hospital 12 de Octubre,
Madrid,
Spain.
aflores.hdoc@salud.madrid.or
10:30-11:00
g.
GMP
protocols
in
the 10:30-11:00
expansion of mesenchymal Potential application of
stem cells (MSCs) for human allogeneic stem cells in
implantation. Rosa María bone regeneration. Rosaria
Gonzalo, Hospital Puerta de Giordano.
Cell
Factory
Hierro,
Madrid,
Spain Policlinico
Milano,
Italy.
rosamaria.gonzalo@salud.madrid.org
[rosaria.giordano@policlinico.
mi.it]Italy
11:00-11:15
Round table discussion on
11:00-11:15
MSCs expansion for clinical
Round table discussion on
use.
different sources of cells.
11:30-13:30
11:30-13:30
ROUND TABLE: Limits of
tissue
repair
in
Orthopaedics. Chair: José
Antonio Rodriguez Montes.
rodriguezmontes@gmail.co
m
11:30-13:30
ROUND TABLE: Basic and
applied strategies in bone
regeneration. Chair: G. Ciapetti
12:00-12:30
Limits and opportunities
for stem cell therapy in
neural damage.
Juan A. Barcia Hospital
Clínico San Carlos, Madrid,
Spain.
[Juan.A.Barcia@uv.es],
11:30-13:30
ROUND
TABLE:
Neural
damage and regeneration.
Chair: JA Barcia.
11:30-13:30
ROUND TABLE: Clinical studies
on bone. Chair:
Enrique
Gomez-Barrena
11:30-11:55
Cell tracking in regenerative
medicine. Advantages and
disadvantages of different
11:30-12:00
Bone
defects,
normal markers Reinhold Erben
healing and impairment reinhold.erben@vu-wien.ac.at
Austria
EGB
11:30-12:00
Neural stem cell proliferation
and differentiation in vitro and
in vivo. Mª Salomé Siserol.
Centro
de
Investigación
Príncipe Felipe, Valencia,
Spain. msirerol@ochoa.fib.es
11:55-12:20
Biomedical
imaging
of
laboratory animals Sebastian
Cerdan
Instituto
de
Investigaciones Biomédicas,
CSIC,
Madrid,
Spain
scerdan@iib.uam.es
Spain.
11:30-12:00
BM concentration in bone
repair. Rationale and clinical
application. Philippe Hernigou
Hôpital Henri Mondor, CréteilParis,
France.
philippe.hernigou@wanadoo.f
r France
12:00-12:30
Biomaterials for neural tissue
regeneration. Ana Paula Pego.
Portugal
apego@ineb.up.pt
Portugal
jabarcia.hcsc@salud.madrid
.org
12:20-12:45
Approaches
to
Bone
Regeneration
by
Gene
12:30-13:00
Nuria
Vilaboa.
Cartilage defects and limits Therapy.
of repair. Pedro Guillén . Hospital La Paz, Madrid, Spain.
Clinica Cemtro, Madrid, nvilaboa@gmail.com
Spain.
consultapg@clinicacemtro. 12:45-13:10
Bone regeneration in the
com
setting
of
osteopenia.
Therapeutic strategies. Pedro
13:00-13:30
Round table discussion on Esbrit. Fundación Jimenez
Madrid,
Spain
tissue
repair
and Diaz,
opportunities
for pesbrit@fjd.es
DISCUSSION 13:10-13:30
regenerative medicine.
12:00-12:30
Expanded MSCs in bone repair
and regeneration. Philippe
Rosset. CHU Tours, Tours,
France.
rosset@med.univtours.fr France
11:30-13:30
ROUND TABLE: Beyond bone
and cartilage: lessons learned
from other tissues and cells.
Chair: Gustav Steinhoff.
11:30-12:00
MSCs therapies in other
locations: the case of cardiac
regeneration. Gustav Steinhof
gustav.steinhoff@med.unirostock.de Germany
12:00-12:30
May MSCs become an
injectable drug? Nan Ma
nan.ma@med.uni-rostock.de
12:30-13:00
The tandem telocytes and
12:30-13:00
stem cells in regenerative
Neural injury: spinal cord and 12:30-13:00
medicine. L Popescu.
peripheral nerve regeneration. The risks of human MSCs lpopescu@jcmm.org
Eva Sykova
therapies.
Luc
Sensebé
Etablissement
Français
de
Sang, 13:00-13:15
sykova@biomed.cas.cz
Toulouse,
France.
Czecj Republic
Discussion
luc.sensebe@efs.sante.fr
France
13:00-13:30
Round table discussion on
13:15-13:30
13:00-13:30
neural
damage
and
FINAL AND CLOSURE
Round table discussion on
regeneration.
clinical studies on bone,
benefits and risks.
LUNCH
13:30-15:30
15:30-17:30
15:30-17:30
ROUND TABLE: Ethical and
regulatory requirements.
Chair: Isabel Varela-Nieto
Instituto de Investigaciones
Biomédicas, CSIC, Madrid,
Spain ivarela@iib.uam.es
15:30-17:30
ROUND TABLE: Biomaterials.
Chair:
Kristine
Arvidson.
University of Bergen, Norway (
[Kristina.ArvidsonFyrberg@iko.uib.no].
Student presentations
15:30-16:00
discussion
Scaffolds for bone tissue
regeneration: overview and
nanotechnology advances. M
Vallet-Regi
Universidad
Complutense de Madrid,
Spain. vallet@farm.ucm.es
15:30-16:00
Overview
of
ethical
requirements: ESF Science
Policy Briefing on human
stem cell research. Maria
Manuela Nogueira. EFS,
Strasbourg,
France.
MNogueira@esf.org
16:00-16:30
Calcium phosphate cements
16:00-16:30
and
foams
for
tissue
European legal framework engineering and regenerative
and public instruments to medicine. Maria Pau Ginebra
support Stem Cell research. Universidad Politécnica de
Javier Arias -Diaz. Instituto Cataluña, Barcelona, Spain.
de Salud Carlos III, Madrid, Maria.Pau.Ginebra@upc.ed .
Spain javardi@isciii.es
Spain
16:30-17:00
Regulatory requirements of
cell therapies. Cristina
Avendaño-Solá.
Hospital
Puerta de Hierro, Madrid,
Spain.
cavendano.hpth@salud.ma
drid.org
17:00-17:30
Round discussion pros and
cons of investigator-driven
15:30-17:30
ROUND
TABLE:
Student
presentations.
Chair:
Y.
Konttinen.
16:30-17:00
MSCs in bone scaffolds:
surface and survivorship P.
Layrolle.
France
Inserm,
Nantes,
France.
pierre.layrolle@inserm.fr
17:00-17:30
Round discussion on tissue
engineering and biomaterials
15:30-17:30
ROUND
TABLE:
Morphogenesis, development
and differentiation. Chair:
Francisco J Blanco
and 15:30-16:00
Tooth morphogenesis and
cytodifferentiation. Thimios
Mitsiadis
,
Zurich,
Switzerland..
thimios.mitsiadis@zzm.uzh.ch
Switzerland
16:00-16:30
Morphogenesis and limb
development. Juan M. Hurle
Universidad de Cantabria,
Santander,
Spain.
hurlej@unican.es
Spain
16:30-17:00
The creation of a biological
joint: manufacturing a living
osteochondral implant by
developemental engineering.
Frank
Luyten
Leuven
University,
Belgium.
frank.luyten@uzleuven.be
Belgium
17:00-17:30
Round
discussion
morphogenesis
development
on
and
clinical trials.